USE OF 2,3 ALKYLCARBONYLOXYBENZOIC ACIDS, DERIVATIVES AND ANALOGUES THEREFROM IN THE TREATMENT OF TISSUE AND CELLULAR DYSFUNCTION DAMAGE AND INJURY IN MAMMALS

Details for Australian Patent Application No. 2003252178 (hide)

Owner ADVANCES LIFE SCIENCES, INC.

Inventors STEC, Karen J.; RUBINSTEIN, Israel; EIZNHAMER, David; XU, Ze-Qi; FLAVIN, Micheal

Pub. Number AU-A-2003252178

PCT Number PCT/US03/23644

PCT Pub. Number WO2004/010989

Priority 60/398,523 25.07.02 US

Filing date 18 July 2003

Wipo publication date 16 February 2004

International Classifications

A61K 031/215

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 60/398,523 25.07.02 US

25 March 2004 Application Open to Public Inspection

  Published as AU-A-2003252178

21 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003252179-ION CHANNEL RECEPTOR AND USES THEREOF

2003252177-MICROFLUIDIC DEVICE INCLUDING PURIFICATION COLUMN WITH EXCESS DILUENT, AND METHOD